B. Nelson

发表

Bactericidal/permeability-increasing protein (rBPI21) in patients with hemorrhage due to trauma: Results of a multicenter phase II clinical trial

J. Minei, D. Demetriades, J. S. Smith, 1999 .

Preliminary evaluation of recombinant amino-terminal fragment of human bactericidal/permeability-increasing protein in children with severe meningococcal sepsis

B. Giroir, S. Carroll, P. Scannon, 1997, The Lancet.

Plasma bactericidal/permeability‐increasing protein concentrations in critically ill children with the sepsis syndrome

J. Carcillo, H. Wong, L. Doughty, 1995, The Pediatric infectious disease journal.

Evaluation of a CD5-specific immunotoxin for treatment of acute graft-versus-host disease after allogeneic marrow transplantation.

H. Deeg, K. Sullivan, R. Storb, 1996, Blood.

Inhibition of endotoxin-induced cytokine release and neutrophil activation in humans by use of recombinant bactericidal/permeability-increasing protein.

A. Eerenberg, N. Friedmann, N. Wedel, 1995, The Journal of infectious diseases.

rBPI2, IN THE PREVENTION OF THE INFLAMMATORY RESPONSE AFTER LIVER RESECTION IN PATIENTS: RESULTS OF THE LOW DOSE PHASE.: 635

M. Cuesta, C. Hack, S. Meijer, 1997 .

Inhibition of endotoxin-induced activation of the coagulation and fibrinolytic pathways using a recombinant endotoxin-binding protein (rBPI23).

J. T. ten Cate, S. V. van Deventer, M. Levi, 1995, Blood.

Recombinant endotoxin-binding protein (rBPI23) attenuates endotoxin-induced circulatory changes in humans.

R. D. de Winter, S. V. van Deventer, N. Friedmann, 1995, Journal of inflammation.

A PHASE I SAFETY AND PHARMACOKINETIC STUDY OF A RECOMBINANT AMINO TERMINAL FRAGMENT OF BACTERICIDAL/ PERMEABILITY‐INCREASING PROTEIN IN HEALTHY MALE VOLUNTEERS

A. Kung, N. Friedmann, N. Wedel, 1996, Shock.